Kathleen Mullane
Infectious Disease · Chicago, ILNPI 1831251388
Payments from drug & device makers
Across 399 payments — averaging $11,036 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3.6M
- Merck$451K
- Astellas Pharma Global Development$145K
- Roche Products Limited$62K
- Pfizer$35K
- Qiagen, LLC$14K
- plus $58K from 12 others
Across 9 payments — averaging $399.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 29 | $3,638,133 |
| Merck | 317 | $451,193 |
| Astellas Pharma Global Development | 4 | $144,651 |
| Roche Products Limited | 13 | $62,073 |
| Pfizer | 2 | $35,100 |
| Qiagen, LLC | 4 | $14,459 |
| Mayne Pharma Commercial LLC | 2 | $13,550 |
| GSK | 8 | $10,946 |
| Emergent Biosolutions Inc. | 1 | $6,200 |
| ADMA Biomanufacturing LLC | 1 | $5,000 |
| Stryker | 1 | $5,000 |
| Paratek Pharmaceuticals, Inc. | 6 | $4,823 |
| Shire North American Group Inc | 3 | $4,585 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,263 |
| Astellas Pharma US Inc | 4 | $2,036 |
| Rigel Pharmaceuticals, Inc. | 1 | $1,200 |
| AbbVie | 1 | $995 |
| Ablynx NV | 1 | $130 |
How this compares
$4,403,335 in reported general payments places this provider in the 95th percentile of 368 infectious disease providers in Illinois.
Other infectious disease in Chicago
- Gregory HuhnChicago$3M
- Catherine CreticosChicago$1.7M
- Babafemi TaiwoChicago$1.4M
- Shivanjali ShankaranChicago$1.1M
- Frank PalellaChicago$987K
- Kamaljit SinghChicago$971K
- Richard NovakChicago$960K
- Renslow ShererChicago$821K
- Mariam AzizChicago$491K
- Aniruddha HazraChicago$486K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.